Connect with us

Hi, what are you looking for?


Quest Life Sciences under fire by WHO over defective clinical trials

The clinical research organization has been reprimanded by the World Health Organization over issues with an HIV medication clinical trial.

08/07/2015 // JusticeNewsFlash // (press release)

Greenville, TX – Clinical research organization Quest Life Sciences has come under fire over issues concerning its clinical trials. News Inferno reported that India based organization has been reprimanded by the World Health Organization over issues related to a trial of HIV medications.

One of the alleged issues was electrocardiograms (ECGs) being duplicates for two-thirds of the patients. Reuters quotes the WHO as stating of the issue, “Subject details … and dates had been changed by the company, in the majority of cases, to make the ECGs appear as if they were from each of the different subjects.”

A notice of concern was recently issued to Quest by the United Nations health agency. As noted in the report, the news comes after another India-based company, GVK Biosciences, was the subject of controversy, leading to concerns about the quality of genetic drugs produced in the country.

Media Information:

Phone: 866-598-1315

You May Also Like


State would join dozens of others in enacting legislation based on federal government’s landmark whistleblower statute, the False Claims Act

press release

With a deep understanding of the latest tech, Erbo helps businesses flourish in a digital world.

press release

#Automotive #Carbon #Canister #Market #Projected #Hit #USD New York, US, Oct. 24, 2022 (GLOBE NEWSWIRE) —  According to a comprehensive research report by Market...

press release

Barrington Research Analyst James C.Goss reiterated an Outperform rating on shares of IMAX Corp IMAX with a Price target of $20. As theaters...